Veterinary Medicines

DOLPAC SMALL DOGS TABLETS

Authorised
  • Oxantel pamoate
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
DOLPAC SMALL DOGS TABLETS
DOLPAC 2
Active substance:
  • Oxantel pamoate
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Oxantel pamoate
    111.80
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    10.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    28.80
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/8299159 5/2006
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0183/001
Concerned member states:
  • Austria
  • Cyprus
  • Finland
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Slovenia
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."